Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Courtagen's EpiSeek Test

Premium

Courtagen has released EpiSeek, a targeted next-generation sequencing-based test for epilepsy. The test targets 327 genes that are associated with epilepsy and nonspecific seizure disorders. The test is run out of the company's CLIA certified laboratory on the Illumina MiSeq.